Effect of Lidocaine Infusion on Post Operative Pain Relief and Recovery After Major Abdominal Cancer Surgery

Not Applicable

• Conditions: Health Condition 1: C19- Malignant neoplasm of rectosigmoidjunctionHealth Condition 2: C689- Malignant neoplasm of urinary organ, unspecifiedHealth Condition 3: C55- Malignant neoplasm of uterus, partunspecified

• Registration Number: CTRI/2021/09/036680
• Lead Sponsor: Rajiv Gandhi Cancer Institute and Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

all adult female patients undergoing major abdominal oncosurgeries

Exclusion Criteria

DRUG ALLERGY, PATIENT REFUSAL, ELECTROLYTE IMBALANCE,CARDIAC DISEASE OR ANY CONTRAINDICATION TO THE USE OF IV LIDOCAINE

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TOTAL OPIOID CONSUMPTION, NUMERICAL RATING SCALE FOR PAIN,TIME TO RESCUE ANALGESIA, RECOVERY PROFILETimepoint: T1-END OF SURGERY, T2-T7-2,4,6,8,12,24 HR POST SURGERY

Secondary Outcome Measures

Name	Time	Method
TIME TO RETURN OF GI FUNATION, TIME OF ICU DISCHARGE, LA TOXICITY, INCIDENCE OF CHRONIC PAIN AT 3 MONTHSTimepoint: T1-END OF SURGERY, T2-T7-2,4,6,8,12,24 HR POST SURGERY,T8-3 MONTHS POST SURGERY